INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 111 filers reported holding INHIBRX INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,488 | -31.5% | 1,116,484 | -3.0% | 0.04% | -27.1% |
| Q2 2023 | $29,889 | +36.3% | 1,151,331 | -0.9% | 0.05% | +26.3% |
| Q1 2023 | $21,927 | -11.1% | 1,161,982 | +16.1% | 0.04% | -22.4% |
| Q4 2022 | $24,660 | -99.9% | 1,000,806 | -2.3% | 0.05% | +32.4% |
| Q3 2022 | $18,394,000 | +56.4% | 1,024,744 | -1.1% | 0.04% | +68.2% |
| Q2 2022 | $11,762,000 | -49.3% | 1,036,295 | -0.4% | 0.02% | -29.0% |
| Q1 2022 | $23,180,000 | – | 1,040,415 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |